Ocular Therapeutix (OCUL) Gross Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7,249.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -191.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -33.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -480.00 |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -325.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -325.00 |
| Dec 31, 2025 | -9,060.00 |
| Sep 30, 2025 | 7,293.00 |
| Jun 30, 2025 | -503.00 |
| Mar 31, 2025 | -6,352.00 |
| Dec 31, 2024 | 180.00 |
| Sep 30, 2024 | -5,777.00 |
| Jun 30, 2024 | 6,243.00 |
| Mar 31, 2024 | 10,116.00 |
| Dec 31, 2023 | -48,877.00 |
| Sep 30, 2023 | 4,919.00 |
| Jun 30, 2023 | 31,872.00 |
| Mar 31, 2023 | 26,421.00 |
| Dec 31, 2022 | -67,315.00 |
| Sep 30, 2022 | 73,236.00 |
| Jun 30, 2022 | 110,212.00 |
| Mar 31, 2022 | 61,156.00 |
| Dec 31, 2021 | 1,421.00 |
| Sep 30, 2021 | 1,231.00 |
| Jun 30, 2021 | 6,219.00 |
| Mar 31, 2021 | 10,075.00 |
| Dec 31, 2020 | 42,654.00 |
| Sep 30, 2020 | 50,816.00 |
| Jun 30, 2020 | 116,766.00 |
| Mar 31, 2020 | 99,556.00 |
| Dec 31, 2019 | 191,547.00 |
| Sep 30, 2019 | -79,401.00 |
| Jun 30, 2019 | -108,773.00 |
| Mar 31, 2019 | -65,649.00 |
| Dec 31, 2018 | 89,684.00 |
| Sep 30, 2018 | 19,886.00 |
| Jun 30, 2018 | 9,300.00 |
| Mar 31, 2018 | -18,735.00 |
| Dec 31, 2017 | 19,498.00 |
| Sep 30, 2017 | -59,674.00 |
| Jun 30, 2017 | -153,920.00 |
| Mar 31, 2017 | -12,069.00 |